Core Insights - BioCardia, Inc. is a global leader in cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases [2] - The company will present at the CSI Focus Devices in Heart Failure conference in Frankfurt, Germany, on December 5, 2025 [1] - The presentation will focus on "Intramyocardial Cell Therapy for Ischemic Heart Failure of Reduced Ejection" [1] Company Overview - BioCardia is headquartered in Sunnyvale, California, and specializes in biotherapeutic platforms, including CardiAMP® autologous and CardiALLO™ allogeneic cell therapies [2] - The company has three clinical stage product candidates in development, supported by its Helix™ biotherapeutic delivery and Morph® vascular navigation product platforms [2] Event Details - The CSI Focus D-HF conference will cover advancements in device-based therapy for heart failure, including ventricle restoration strategies and monitoring systems [1] - The session featuring BioCardia's CEO will take place from 10:30 to 11:30 CET [1]

Core Insights - Mixie Technologies, Inc. is transitioning into a technology-centered company focused on platform solutions that support scalable and recurring revenue models [2][6] - The company has entered into a binding Letter of Intent to acquire 25% of HoloTwin LLC, with an option for an additional 26% [1][6] - HoloTwin develops a digital twin platform that integrates operational data from various vendor systems into a unified interface, addressing fragmentation in venue operations [3][10] Company Overview - Mixie Technologies, Inc. operates a unified technology ecosystem that includes AI-enabled solutions, intelligent video processing, and digital twin architecture [8] - The company was formerly known as Pure Harvest Corporate Group, Inc. and has changed its name as of November 2025 [9] Market Opportunity - The global digital twin market is projected to grow from approximately USD 24.48 billion in 2025 to USD 259.32 billion by 2032, with a CAGR of about 40.1% [5] - Another analysis estimates the market size at USD 21.14 billion in 2025, rising to USD 149.81 billion by 2030, with a CAGR near 47.9% [5] HoloTwin's Role - HoloTwin's platform is designed to consolidate various operational systems into a single interface, enhancing situational awareness and decision-making for venue operators [3][4] - The platform has engaged with a major global sports organization to evaluate its effectiveness in managing complex infrastructure environments [4][6] Strategic Alignment - The acquisition of HoloTwin aligns with Mixie's strategy to enhance its technology platform and provide structured solutions to fragmented operational ecosystems [6][10] - The binding LOI establishes a pathway for due diligence and documentation towards a definitive agreement [6][7]

Core Insights - Rush Street Interactive, Inc. (RSI) has been awarded Operator of the Year – North LatAm at the inaugural EGR LatAm Awards, recognizing its leadership in the Colombian and Peruvian markets [1][2] Company Performance - RSI has demonstrated exceptional growth and commercial success in the Latin American market, setting high standards and driving innovation across its business [2][4] - The company has expanded its RushBet brand and proprietary platform into Peru in 2024, reinforcing its leadership in the region's digital gaming market [3] Strategic Focus - The CEO of RSI emphasized the company's commitment to delivering innovative gaming experiences and exceptional customer service, which are central to its performance in the rapidly developing Latin American market [3] - RSI aims to introduce localized and customized gaming products and services to cater to varying regional player preferences [3] Industry Recognition - The EGR LatAm Awards celebrate the best in the betting and gaming sector in South America, recognizing operators that excel in innovation, sustainability, customer experience, and product development [4]

BOCA RATON, FL, Dec. 01, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”), the first public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced it has begun integrating and running the open block-building infrastructure provided by Harmonic across its Solana validator operations. Harmonic introduces competition and choice into Solana’s block-building pipeline. Instead of relying on a single builder, validators can select from multip ...

WOODCLIFF LAKE, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Hudson Technologies, Inc. (NASDAQ: HDSN) announced that its board of directors has approved an increase to the Company’s share repurchase authorization. Hudson may now purchase up to $20 million in shares of its common stock during calendar year 2025, an increase from up to $10 million of outstanding common stock previously authorized for 2025. Furthermore, the board of directors authorized the Company to repurchase up to $20 million of outstanding com ...

Core Insights - Recursion, a clinical stage TechBio company, will present new clinical data from the ongoing TUPELO Phase 1b/2 trial of REC-4881 for Familial Adenomatous Polyposis (FAP) during a webinar on December 8, 2025 [1][2] - The company utilizes a platform called Recursion OS, which integrates various technologies to create one of the largest proprietary biological and chemical datasets, enabling advanced drug discovery [3] Company Overview - Recursion is headquartered in Salt Lake City and is a founding member of BioHive, a collective for the Utah life sciences industry, with additional offices in Montréal, New York, London, and Oxford [4] - The company focuses on decoding biology to improve lives, leveraging machine-learning algorithms to analyze vast datasets and conduct millions of wet lab experiments weekly [3] Leadership and Presenters - The webinar will feature key personnel including Najat Khan, Ph.D. (Chief R&D and Chief Commercial Officer), David Mauro, M.D., Ph.D. (Chief Medical Officer), and other notable experts [6]

Core Insights - Moomoo has launched a strategic out-of-home advertising campaign in New York City targeting daily commuters to enhance brand visibility and user engagement during the Q4 earnings season [1][4][6] Group 1: Campaign Overview - The campaign runs from October 14 to December 13, utilizing digital boards at the World Trade Center station and in-train advertisements, reaching approximately 3.4 million daily commuters [1] - The initiative reflects Moomoo's commitment to a customer-first, data-driven strategy aimed at attracting traders of varying experience levels [4] Group 2: Creative Approach - Moomoo's campaign employs a creative strategy that goes beyond generic features, using industry insights and relatable scenarios to promote smarter trading habits [5] - The campaign is designed to create memorable reminders of Moomoo's data-driven advantages in high-traffic commuter environments [5] Group 3: Performance Metrics - Initial results indicate increased app downloads, brand visibility, and engagement across digital channels, with rising search interest in Moomoo in New York and New Jersey [6] - Cross-channel engagement metrics, including search engine marketing and app store advertising, have shown significant improvement [6] Group 4: Company Commitment - Moomoo's CEO emphasized the campaign's role in empowering U.S. traders through a data-first approach, enabling informed decision-making in a dynamic market [7] - The company is dedicated to providing user-friendly tools and insights to help investors make informed investment decisions [7][8]

Ra’anana, Israel, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (Nasdaq: RVSN) (“Rail Vision” or the “Company”), an early commercialization stage technology company seeking to revolutionize railway safety and the data-related market, today announced the signing of an agreement for a strategic transaction to acquire 51% ownership of Quantum Transportation Ltd. (the “Acquisition” and “Quantum Transportation”), a cutting-edge quantum computing and AI company specializing in error correction technologies. ...

Core Points - Yorkville Acquisition Corp. has confidentially submitted a draft registration statement on Form S-4 with the SEC for a proposed business combination with Trump Media & Technology Group Corp. and Crypto.com [1][2] - The business combination aims to establish Trump Media Group CRO Strategy, Inc., focusing on acquiring the native cryptocurrency token of the Cronos ecosystem (CRO) [1][4] - Upon completion, Yorkville will be renamed Trump Media Group CRO Strategy, Inc. and listed on Nasdaq under the ticker symbol "MCGA" [2] Company Overview - Yorkville Acquisition Corp. is a blank check company incorporated in the Cayman Islands, aiming to effect a merger or similar business combination with established businesses poised for growth [5][6] - Trump Media's mission is to promote free speech through its platforms, including Truth Social and Truth+, and is launching Truth.Fi for financial services [7] - Crypto.com, founded in 2016, is a leader in regulatory compliance and aims to accelerate cryptocurrency adoption [8] Advisors - Clear Street is the exclusive capital markets advisor to Yorkville Acquisition Corp. [3] - DLA Piper LLP (US) serves as legal counsel to Yorkville, while Skadden, Arps, Slate, Meagher & Flom LLP advises Crypto.com [3] Future Strategy - Trump Media Group CRO Strategy, Inc. will focus on strategically investing in digital asset ecosystems and managing CRO [4] - The business combination is subject to SEC review and shareholder approval, with customary closing conditions to be fulfilled [2] Additional Information - Yorkville Acquisition Corp. plans to file a Registration Statement on Form S-4, which will include a preliminary proxy statement and prospectus related to the business combination [9][10] - Shareholders will receive definitive proxy statements and other relevant documents for voting on the business combination [10]

If approved, ReadyFlow Autoinjector would deliver an IV-equivalent diuretic dose (subcutaneous furosemide injection 80 mg/ml) in under 10 secondsWould potentially provide a cost-effective and convenient option to address episodes of fluid buildup at home, benefiting patients, providers and payorsPDUFA target action date of July 26, 2026 WESTLAKE VILLAGE, Calif. and BURLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today announced that the U.S. Food and Drug Administrat ...